HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M200451-JLR200v1 44/4/816    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nassir, F. Articles by Davidson, N. O. Search for Related Content PubMed PubMed Citation Articles by Nassir, F. Articles by Davidson, N. O. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 44, 816-827, April 2003
Copyright © 2003 by Lipid Research, Inc.

Apolipoprotein[a] secretion from hepatoma cells is regulated in a size-dependent manner by alterations in disulfide bond formation

Fatiha Nassir^*, Yan Xie^* and Nicholas O. Davidson^1,*,

^* Departments of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110
Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110

¹ To whom correspondence should be addressed. e-mail: nod{at}im.wustl.edu

Apolipoprotein[a] (apo[a]) is a large disulfide linked glycoprotein synthesized by hepatocytes. We have examined the role of disulfide bond formation in the processing of apo[a] using human and rat hepatoma cells expressing apo[a] isoforms containing varying numbers of kringle 4 (K4) domains, following treatment with DTT. Hepatoma cells expressing 6- or 9-K4 isoforms revealed 90% inhibition of apo[a] secretion following DTT treatment, although larger isoforms containing 13- or 17-K4 domains demonstrated continued secretion (up to 30% of control values), suggesting that a fraction of the larger isoforms is at least partially DTT resistant. Wash-out experiments demonstrated that these effects were completely reversible for all isoforms studied, with no enhanced degradation associated with prolonged intracellular retention. DTT treatment was associated with enhanced binding of apo[a] with the endoplasmic reticulum-associated chaperone proteins calnexin, calreticulin, and BiP, which was reversible upon DTT removal. The chemical chaperone 6-aminohexanoic acid, previously demonstrated by others to rescue defective apo[a] secretion associated with alterations in glycosylation, failed to alter the secretion of apo[a] following DTT treatment.

The demonstration that DTT modulates apo[a] secretion in a manner influenced by both the type and number of K4 repeats extends understanding of the mechanisms that regulate its exit from the endoplasmic reticulum.

Supplementary key words lipoprotein[a] • apolipoprotein B-100 • dithiothreitol

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F. Nassir, Y. Xie, B. W. Patterson, J. Luo, and N. O. Davidson Hepatic secretion of small lipoprotein particles in apobec-1-/- mice is regulated by the LDL receptor J. Lipid Res., September 1, 2004; 45(9): 1649 - 1659. [Abstract] [Full Text] [PDF]

				M. Tateyama, H. Liu, A-S. Yang, J. W. Cormier, and R. S. Kass Structural Effects of an LQT-3 Mutation on Heart Na+ Channel Gating Biophys. J., March 1, 2004; 86(3): 1843 - 1851. [Abstract] [Full Text] [PDF]